Ji J, Mitra A, Camidge DR, Riess JW, et al. Early Alectinib Resistance From MET Amplification in ALK-Rearranged NSCLC: Response to Crizotinib with Re-Response to Alectinib and Crizotinib. Clin Lung Cancer 2021;22:e851-e855.
PMID: 34059475